Hypercalæmi Bonviva kan, ligesom andre intravenøst administrerede bisphosphonater, forårsage et forbigående fald i værdierne for serum calcium.
Hypocalcaemia Bonviva, like other bisphosphonates administered intravenously, may cause a transient decrease in serum calcium values.